• I.N. Todor R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology
  • N.Yu. Lukianova R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology
  • M.A. Primin V.M. Glushkov Institute of Cybernetics
  • I.V. Nedayvoda V.M. Glushkov Institute of Cybernetics
  • V.F. Chekhun R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology



drug resistance, ferromagnetic nanoparticles, magnetism, SQUID-magnetometry, tumor


Magnetic signals emitted by living organisms, regardless of a biological species, are important biophysical indicators. The study of these indicators is very relevant and promising for the visualization of the tumor process and the development of technologies using artificial intelligence when it comes to malignant neoplasms, particularly resistant to chemotherapy. Aim: To measure magnetic signals from transplantable rat tumors and their counterparts resistant to cytostatics for evaluating the features of the accumulation of iron-containing nanocomposite Ferroplat. Materials and Methods: Doxorubicin (Dox)-sensitive and Dox-resistant Walker-256 carcinosarcoma and cisplatin-sensitive and cisplatin-resistant Guerin’s carcinoma transplanted in female Wistar rats were studied. The magnetism of tumors, liver and heart was determined using Superconductive Quantum Interference Device (SQUID) — magnetometry in a non-contact (13 mm over the tumor) way using specially designed computer programs. In a group of the experimental animals, a ferromagnetic nanocomposite (Ferroplat) was administered as a single intravenous injection and biomagnetism was assessed in 1 h. Results: The magnetic signals coming from Dox-resistant Walker-256 carcinosarcoma in the exponential growth phase were significantly higher in comparison with sensitive tumor. Intravenous administration of Ferroplat increased biomagnetism by at least an order of magnitude, especially in resistant tumors. At the same time, the magnetic signals of the liver and heart were within the magnetic noise. Conclusion: The use of SQUID-magnetometry with ferromagnetic nanoparticles as a contrast agent is a promising approach for visualization of malignant neoplasms with varying sensitivity to chemotherapy.


Rivas J, Bañobre-López M, Piñeiro-Redondo Y, et al. Magnetic nanoparticles for application in cancer therapy. J Magnet Magnet Mat 2012; 324: 3499–502. doi:

Arriortua OK, Garaio E, Herrero de la Parte B, et al. Antitumor magnetic hyperthermia induced by RGD-functionalized Fe3O4 nanoparticles, in an experimental model of colorectal liver metastases. Beilstein J Nanotechnol 2016; 7: 1532–42.

Chang D, Lim M, Goos JACM, et al. Biologically targeted magnetic hyperthermia: potential and limitations. Front Pharmacol 2018; 9: 831. doi: 3389/fphar.2018.00831

Balejcikova L, Molcan M, J.Kovac J, et al. Hyperthermic effect in magnetoferritin aqueous colloidal solution. J Mol Liq 2019; 283: 39–44. doi:

Jose J, Kumar R, Harilal S, et al. Magnetic nanoparticles for hyperthermia in cancer treatment: an emerging tool. Envir Sci Poll Res 2020; 27: 19214–25. doi:

Chao Y, Chen G, Liang Ch, et al. Iron nanoparticles for low-power local magnetic hyperthermia in combination with immune checkpoint blockade for systemic antitumor therapy. Nano Lett 2019; 19: 4287–96. doi:

Kwon S-H, Faruque HA, Kee H, et al. Exosome-based hybrid nanostructures for enhanced tumor targeting and hyperthermia therapy. Coll Surf B: Biointerfaces 2021; 205: 111915. doi:

Patitsa M, Karathanou K, Kanaki Z, Tzioga L. Magnetic nanoparticles coated with polyarabic acid demonstrate enhanced drug delivery and imaging properties for cancer theranostic applications. Sci Rep 2017; 7: 775. doi:

Khafaji M, Zamani M, Vossoughi M, Iraji zad A. Doxorubicin/cisplatin-loaded superparamagnetic nanoparticles as a stimuli-responsive co-delivery system for chemo-photothermal therapy. Int J Nanomed 2019; 14: 8769–86. doi:

Lee S-Ju, Kim J-J, Kang K-Yu. Enhanced anti-tumor immunotherapy by silica-coated magnetic nanoparticles conjugated with ovalbumin. Int J Nanomed 2019; 14: 8235–49. doi:

Angeli JPF, Friedmann, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer 2019; 19: 405–14. doi:

Baxevanis CN, Fortis SP, Ardavanis A, Perez SA. Exploring essential issues for improving therapeutic cancer vaccine trial design. Cancers 2020; 12: 2908. doi:

Gao A, Hu X-L, Saeed M, et al. Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy. Acta Pharm Sin 2019; 40: 1129–37. doi:

Li K, Lu L, Xue Ch, et al. Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo. Nanoscale 2020; 12: 130–44. doi:

Asadujjaman M, Cho KH, Jang DJ. Nanotechnology in the arena of cancer immunotherapy. Arch Pharm Res 2020; 43: 58–79. doi:

Gupta J, Safdari HA, Hoque M. Nanoparticle mediated cancer immunotherapy. Semin Cancer Biol 2021; 69: 307–24. doi: 20.1016/j.semcancer.2020.03.015

Yang M, Li J, Gu P, Fan X. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Bioact Mater 2020; 6: 1973–87. doi:

Yao Y, Zhou Y, Liu L, et al. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front Mol Biosci 2020; 7: 193. doi:

Todor IN, Lukianova NYu, Primin MA, et al. Biomagnetism of rats with Guerin’s carcinoma after injection of ferromagnetic nanocomposite (Ferroplat): contactless measurement. Exp Oncol 2020; 42: 204–7. doi:

Chekhun VF, Lukianova NYu, Todor IM, et al. Pharmacokinetics and biological effects of ferromagnetic nanocomposite in rats with sensitive and ddp-resistant Guerin’s carcinoma. Toxi App Phar Insig 2018; 1: 1–8.

Chekhun VF, Lukianova NYu, Burlaka AP, et al. Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin. Intern J Oncol 2013; 43: 1481–6. doi:

Chekhun V, Lukianova N, Demash D, et al. Manifestation of key molecular genetic markers in pharmacocorrection of endogenous iron metabolism in MCF-7 and MCF-7/DDP human breast cancer cells. CellBio 2013; 3: 217–27. doi:

Chekhun VF, Yurchenko OV, Naleskina LA, et al. In vitro modification of cisplatin cytotoxicity with magnetic fluid. Exp Oncol 2013; 35: 15–9.

Chekhun VF, Todor IN, Lukianova NY, et al. Influence of ferromagnetic nanocomposite (ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism. Exp Oncol 2018; 40: 268–74.

Abedini-Nassab R, Pouryosef Miandoab M, Șaşmaz M. Microfluidic synthesis, control, and sensing of magnetic nanoparticles: a review. Micromachines 2021; 12: 768. doi:

Araύjo JFDF, Carvalho HR, Louro SRW, et al. SQUID and Hall Effect magnetometers for detecting and characterizing nanoparticles used in biomedical applications. Brazil J Phys 2022; 52: 46. doi:




How to Cite

Todor, I., Lukianova, N., Primin, M., Nedayvoda, I., & Chekhun, V. (2023). BIOMAGNETISM OF DRUG-SENSITIVE AND DRUG-RESISTANT MALIGNANT TUMORS AFTER INJECTION OF FERROMAGNETIC NANOCOMPOSITE. Experimental Oncology, 44(4), 320–323.



Short communications

Most read articles by the same author(s)

1 2 > >>